ADIPOQ and metabolic dysfunction-associated steatotic liver disease: Adiponectin exerts it biological effect via adiponectin receptors (AdipoR1/R2) via AMPK to potentially regulate the hepatic metabolism of lipids and inhibit lipogenesis genes (FAS and ACC), leading to reversal of NAFLD [17].